Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

Background: Most of the patients with Pancreatic Ductal Adenocarcinoma (PDA) are not eligible for a curative surgical resection. For this reason there is an urgent need for personalized therapies. PDA is the result of complex interactions between tumor molecular profile and metabolites produced by i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Follia, Laura, Ferrero, Giulio, Mandili, Giorgia, Beccuti, Marco, Giordano, Daniele, Spadi, Rosella, Satolli, Maria Antonietta, Evangelista, Andrea, Katayama, Hiroyuki, Hong, Wang, Momin, Amin A., Capello, Michela, Hanash, Samir M., Novelli, Francesco, Cordero, Francesca
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400843/
https://ncbi.nlm.nih.gov/pubmed/30873387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00115
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares